Work

41P A window-of-opportunity study with atezolizumab and the oncolityc virus pelareorep in early breast cancer (REO-027, AWARE-1)

Year: 2020

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2020.03.175

Authors: L. Manso, P. Villagrasa, N. Chic, J.M. Cejalvo, Y. Izarzugaza, B. Cantos, S. Blanch, M. Juan, B. González-Farré, R. Laeufle, G. Nuovo, G. Wilkinson, M. Coffey, A. González, D. Martínez, L. Paré, F. Salvador, X. González-Farré, A. Prat, J. Gavila Gregori

Institutions: Hospital Universitario 12 De Octubre, Solti, Hospital Clínic de Barcelona, Hospital Clínico Universitario de Valencia, Hospital Universitario Fundación Jiménez Díaz, Hospital Universitario Puerta de Hierro Majadahonda, Fundación Instituto Valenciano de Oncología, Oncolytics Biotech (Canada), The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Hospital General de Catalunya

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3026759727

FWCI: 0.12

Cites:

Cited by: 2

Related to: 10